142 related articles for article (PubMed ID: 26084603)
1. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
Chen L; Malone KE; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
[TBL] [Abstract][Full Text] [Related]
2. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
4. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
5. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
6. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
7. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
8. A cohort study of antihypertensive medication use and breast cancer among Danish women.
Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
[TBL] [Abstract][Full Text] [Related]
9. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
10. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
11. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
12. Relationship between diabetes and risk of second primary contralateral breast cancer.
Li CI; Daling JR; Tang MT; Malone KE
Breast Cancer Res Treat; 2011 Jan; 125(2):545-51. PubMed ID: 20625814
[TBL] [Abstract][Full Text] [Related]
13. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
14. The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics.
Goldvaser H; Rizel S; Hendler D; Neiman V; Shepshelovich D; Shochat T; Sulkes A; Brenner B; Yerushalmi R
Oncology; 2016; 91(4):217-223. PubMed ID: 27544756
[TBL] [Abstract][Full Text] [Related]
15. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
18. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.
Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH
JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular outcomes and antihypertensive drug treatment in older women.
Staessen JA; Thijs L; Wang J; Li Y
JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972
[No Abstract] [Full Text] [Related]
20. Cardiovascular outcomes and antihypertensive drug treatment in older women.
Bursztyn M
JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971
[No Abstract] [Full Text] [Related]
[Next] [New Search]